Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Oral Antineoplastic Agents”

49 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 49 results

Not applicableStudy completedNCT04626830
What this trial is testing

Mobile Application to Assist Adherence to Oral Anticancer Agents and Symptom Management

Who this might be right for
CancerAdherence to Medication RegimeSymptom Management
Baskent University 77
Testing effectiveness (Phase 2)Study completedNCT03672240
What this trial is testing

Study of APL-1202 in Non-Muscle Invasive Bladder Cancer Patients Who Are Resistant to One Induction Course of BCG Treatment

Who this might be right for
Non-Muscle Invasive Bladder Cancer (NMIBC)
Asieris Pharmaceutical Technologies Co., Ltd. 6
Early research (Phase 1)Study completedNCT02171221
What this trial is testing

Phase I Study of Oral DFP-11207 in Solid Tumors

Who this might be right for
Solid TumorsCancer
Delta-Fly Pharma, Inc. 23
Testing effectiveness (Phase 2)Study completedNCT00002188
What this trial is testing

ALRT1057 in Patients With AIDS-Related Kaposi's Sarcoma

Who this might be right for
Sarcoma, KaposiHIV Infections
Anderson Clinical Research 27
Early research (Phase 1)Temporarily pausedNCT00264472
What this trial is testing

5 Fluorouracil and the Anti-Tumor Activity of ADH300004 and 5 Fluorouracil in Subjects With Incurable Solid Tumors

Who this might be right for
Neoplasms
Adherex Technologies, Inc. 60
Not applicableStudy completedNCT01947296
What this trial is testing

Impact of a Coordinated Regional Organization to Secure Patient's Care Treated by Oral Antineoplastic Agents

Who this might be right for
Cancer
Assistance Publique - Hôpitaux de Paris 284
Not applicableEnded earlyNCT04595851
What this trial is testing

Pharmacists Coordinated Care Oncology Model (PCOM) for Patients Taking Oral Anti-cancer Medications

Who this might be right for
Chronic Myeloid LeukemiaChronic Lymphocytic LeukemiaMultiple Chronic Conditions
University of Michigan Rogel Cancer Center 6
Not applicableUnknownNCT04663100
What this trial is testing

Oral Adherence in Hematological Oncology Agents and Impact on Comorbid Therapy Adherence

Who this might be right for
Chronic Myeloid LeukemiaChronic Lymphocytic LeukemiaMultiple Myeloma+1 more
University of Tennessee 30
Not applicableStudy completedNCT03972527
What this trial is testing

Photobiomodulation to Demonstrate Safety and Reduce the Incidence of Oral Mucositis in Adult Head & Neck Cancer Patients

Who this might be right for
Oral Mucositis (Ulcerative)Oral Mucositis (Ulcerative) Due to RadiationOral Mucositis (Ulcerative) Due to Antineoplastic Therapy+1 more
MuReva Phototherapy Inc. 85
Not applicableUnknownNCT03605186
What this trial is testing

Prevention of Oral Mucositis After Using Chamomile Oral Cryotherapy Versus Oral Cryotherapy in Pediatric Cancer Patients Receiving Chemotherapy.

Who this might be right for
Oral Mucositis (Ulcerative) Due to Antineoplastic Therapy
Cairo University 20
Early research (Phase 1)Study completedNCT00000689
What this trial is testing

Phase I Trial of mBACOD and Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in AIDS-Associated Large Cell, Immunoblastic, and Small Non-cleaved Lymphoma

Who this might be right for
Lymphoma, Non-HodgkinHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 18
Early research (Phase 1)Study completedNCT00479076
What this trial is testing

A Phase I Study of Intravenous Aflibercept in Combination With S-1 in Japanese Cancer Patients

Who this might be right for
Neoplasms
Sanofi 22
Large-scale testing (Phase 3)Study completedNCT04603924
What this trial is testing

Study of Niclosamide in Moderate and Severe Hospitalized Coronavirus-19 (COVID-19) Patients

Who this might be right for
COVID-19
NeuroBo Pharmaceuticals Inc. 49
Early research (Phase 1)Study completedNCT00000998
What this trial is testing

Trimetrexate in the Treatment of Pneumocystis Carinii Pneumonia (PCP) in Patients With AIDS Not Previously Treated for PCP

Who this might be right for
Pneumonia, Pneumocystis CariniiHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 50
Early research (Phase 1)Study completedNCT00001449
What this trial is testing

A Phase I Study of Weekly Gemcitabine in Combination With Infusional Fluorodeoxyuridine and Oral Calcium Leucovorin in Adult Cancer Patients

Who this might be right for
Neoplasms
National Cancer Institute (NCI) 60
Not applicableUnknownNCT02468245
What this trial is testing

Does a Nursing Intervention Improve Adherence to Oral Chemotherapies in the Outpatient Cancer Treatment Setting?

Who this might be right for
Antineoplastic Agents
Bassett Healthcare 60
Not applicableUnknownNCT04550533
What this trial is testing

DESIGN OF A SCALE TO MEASURE COMPLIANCE WITH DRUG TREATMENT IN PATIENTS WITH ORAL CHEMOTHERAPY

Who this might be right for
Adherence, Medication
Universidad Miguel Hernandez de Elche 288
Testing effectiveness (Phase 2)Active Not RecruitingNCT06710847
What this trial is testing

Investigate the Safety, Pharmacokinetics, and Preliminary Effectiveness of GSK4418959 Alone or in Combination With Other Anti-cancer Agents in Participants With Solid Tumors

Who this might be right for
Neoplasms, ColorectalSolid TumorColon Cancer+2 more
GlaxoSmithKline 14
Testing effectiveness (Phase 2)UnknownNCT04472143
What this trial is testing

Granisetron Transdermal Patch for Prophylaxis of Nausea and Vomiting in Patients Receiving Oral Anticancer Agents

Who this might be right for
Chemotherapy-induced Nausea and Vomiting (CINV)
Fudan University 60
Early research (Phase 1)Study completedNCT00676299
What this trial is testing

A Safety and Dose-finding Study of JNJ-26483327, a Drug in Development for Cancer, for Patients With Advanced and/or Refractory Solid Malignancies.

Who this might be right for
Protein Kinase InhibitorsAntineoplastic ProtocolsClinical Trial, Phase 1+4 more
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 19
Load More Results